This work is licensed under a
Creative Commons Attribution 4.0 International License
R. Webster, Neurotransmitters, Drugs and Brain Function, John Wiley & Sons, London, 2005, 5-67.
H. Kaplan, B. Sadock, Synopsis of Psychiatry, 7th Edition, William & Wilkins, Maryland, (1994).
M. Padurariu, A. Ciobica, R. Lefter, I. Serban, C. Stefanescu, R. Chirita, The oxidative stress hypothesis in Alzheimer's disease, Psychiatr Danub. 25 (2013) 401-9.
S. Gauthier, M. Emre, M. Farlow, R. Bullock, G. Grossberg S. Potkin, Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors, Curr Med Res Opin. 19 (2003) 707-714.
Z. Ji, T. Dong, W. Ye, R. Choi, C. Lo, K. Tsim, Ginsenoside Re attenuate β-amyloid and serum-free induced neurotoxicity in PC12 cells, J Ethnopharmacol. 107 (2006) 48-52.
M. Findeis, Approaches to discovery and characterization of inhibitors of amyloid-beta peptide polymerization, Biochim Biophys Acta. 1502 (2000) 76-84.
M. Padurariu, A. Ciobica, I. Mavroudis, D. Fotiou, S. Baloyannis, Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients, Psychiatr Danub. 24 (2012) 152-8.
S. Scheff, D. Price, F. Schmitt, M. Scheff, E. Mufson, Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease, J Alzheimers Dis. 24 (2011) 54757.
R. Pinder, Is Alzheimer's a Preventable Disease?, Annals of General Psychiatry. 7 (2008) 1.
I. Serban, C. Toarba, S. Hogas, A. Covic, A. Ciobica, R. Chirita, M. Graur, The relevance of body mass index in the cognitive status of diabetic patients with different alcohol drinking patterns, Arch. Biol. Sci. 66 (2014) 347-353.
A. Basli, S. Soulet, N. Chaher, J. Mérillon, M. Chibane, J. Monti, T. Richard, Winepolyphenols: potential agents in neuroprotection, Oxid Med Cell Longev. 2012 (2012) 805762.
J. Coyle, P. Kershaw, Galantamine a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease, Biol Psychiatry. 49 (2001) 289-299.
M. Mehta, A. Adem, M. Sabbagh, New acetylcholinesterase inhibitors for Alzheimer's disease, IJAD. 2012 (2012) 928-983.
I. Kang, Y. Jeon, X. Yin, J. Nam, S. You, M. Hong et al., Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid and reduces beta-amyloid mediated neuronal death, Food Chem Toxicol. 49 (2011) 2252-2259.
M. Yu, A. Wong, K. So, J. Fang, W. Yuen, R. Chang, New polysaccharide from Nerium indicum protects neurons via stress kinase signaling pathway. Brain Res. 1153 (2007) 221-230.
N. Gericke, Plants, products and people: Southern African perspectives. Advances in Phytomedicine, Elsevier, Amsterdam, 2002, 155-162.
E. Adewusi, N. Moodley, V. Steenkamp, In vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from southern Africa. Asian Pac J Trop Med. 4 (2011) 829-835.
R. Cao, W. Peng, Z. Wang, A. Xu, Beta-Carboline alkaloids: biochemical and pharmacological functions, Curr Med Chem. 14 (2007) 479-500.
M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, C. Stefanescu, Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease, Neurosci Lett. 469 (2010) 6-10.
L. Hritcu, V. Bild, H. Foyet, A. Ciobica, I. Serban, D. Timofte, E. Anton, Antioxidative effects of the methanolic extract of Hibiscus asper leaves in mice, Romanian Biotechnological Letters. 19 (2014) 9376-9383.
M. Sano, S. Salloway, Moving from treatment to prevention in Alzheimer's disease with vitamin E and estrogen, Psychiatric Times, (1999).
E. Abner, F. Schmitt, M. Mendiondo, J. Marcum, R. Kryscio, Vitamin E and all-cause mortality: a meta-analysis, Curr Aging Sci. 4 (2011) 158-70.
E. Miller, R. Pastor-Barriuso, D. Dalal, R. Riemersma, L. Appel, E. Guallar, Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality, Ann Intern Med. 142 (2005) 37-46.
B. Drever, W. Anderson, G. Riedel, D. Kim, J. Ryu, D. Choi, B. Platt, The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. J Pharmacol Sci. 107 (2008) 380-392.
M. Golechha, J. Bhatia, D. Arya, Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice, J Environ Biol. 33 (2012) 95-100.
K. Selvendiran, J. Singh, K. Krishnan, D. Sakthisekaran, Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice, Fitoterapia. 74 (2003).
K. Srinivasan, Black pepper and its pungent principle-piperine: a review of diverse physiological effects, Crit Rev Food Sci. 47 (2007) 735-748.
M. Azzubaidi, A. Saxena, N. Talib, Q. Ahmed, B. Dogarai, Protective effect of treatment with black cumin oil on spatial cognitive functions of rats that suffered global cerebrovascular hypoperfusion, Acta Neurobiol Exp (Wars). 72 (2012) 154-165.
T. Dillinger, P. Barriga, S. Escárcega, M. Jimenez, D. Salazar Lowe et al., Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate, J Nutr. 130 (2000) 2057S-2072S.
M. Galleano, P. Oteiza, C. Fraga, Cocoa, chocolate, and cardiovascular disease, J Cardiovasc Pharmacol. 54 (2009) 483-490.
A. Nehlig, The neuroprotective effects of cocoa flavanol and its influence on cognitive performance, Br J Clin Pharmacol. 75 (2013) 716-727.
K. Rahman, Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 22 (2007) 219-236.
B. Zhao, X. Li, R. He, S. Cheng, W. Xin, Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals, Cell Biophys. 14 (1989) 175-185.
M. Singh, M. Arseneaul, T. Sanderson, V. Murthy, C, Ramassamy, Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms, J Agric Food Chem. 56 (2008) 4855-4873.
D. Katz, K. Doughty, A. Ali, Cocoa and chocolate in human health and disease, Antioxid Redox Signal. 15 (2011) 2779-2811.
D. Kim, J. Kim, Y. Han, Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult, J Altern Complement Med. 13 (2007) 333-340.
J. Dugoua, D. Seely, D. Perri, K. Cooley, T. Forelli et al., From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark, Can J Physiol Pharmacol. 85 (2007) 837-847.
A. Khan, M. Safdar, M. Ali Khan, K. Khattak, R. Anderson, Cinnamon improves glucose and lipids of people with type 2 diabetes, Diabetes Care. 26 (2003) 3215-3218.
S. Brahmachari, A. Jana, K. Pahan, Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses, J Immunol. 183 (2009) 5917-5927.
B. Ouattara, R. Simard, R. Holley, G. Piette, A. Begin, Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms, Int J Food Microbiol. 37 (1997) 155-162.
D. Peterson, R. George, F. Scaramozzino, N. LaPointe, R. Anderson et al., Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro, J Alzheimers Dis. 17 (2009) 585-597.
R. Anderson, C. Broadhurst, M. Polansky, W. Schmidt, A. Khan et al, Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity, J Agric Food Chem. 52 (2004) 65-70.
S. Bastianetto, S. Krantic, R. Quirion, Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease, Mini Rev Med Chem. 8 (2008) 429-435.